Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 22.3B | 21.1B | 25.8B | 22.2B |
Cost of revenue | 20.5B | 17.4B | 22.0B | 18.4B |
Gross profit | 1.8B | 3.7B | 3.8B | 3.7B |
Operating expense | ||||
Research & development | 303M | 293M | 311M | 272M |
Selling general and admin | 495M | 484M | 593M | 396M |
Other operating expenses | -89M | -118M | -1.2B | -87M |
Operating income | 1.1B | 3.1B | 4.1B | 3.2B |
Non operating interest income | ||||
Income | 41M | 34M | 39M | 44M |
Expense | 370M | 339M | 372M | 350M |
Other income expense | — | — | — | — |
Pretax income | 765M | 2.8B | 3.8B | 2.9B |
Tax provision | 190M | 565M | 771M | 577M |
Net income | 575M | 2.2B | 3.0B | 2.3B |
Basic EPS | 2.0 | 8.0 | 11.0 | 8.3 |
Diluted EPS | 2.0 | 8.0 | 11.0 | 8.3 |
Basic average shares | 284.1M | 274.2M | 273.5M | 273.5M |
Diluted average shares | 284.1M | 274.2M | 273.5M | 273.5M |
EBITDA | 3.4B | 4.9B | 6.0B | 4.9B |
Net income from continuing op. | 765M | 2.8B | 3.8B | 2.9B |
Minority interests | -2M | -2M | -1M | -1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |